Navigation Links
Leading Anti-Aging Prescription RENOVA(R) Continues To Deliver Maximum Results
Date:9/9/2009

NEW YORK, Sept. 9 /PRNewswire/ -- In 2008, the global anti-aging skincare market approached $15 billion(1), with 32 percent of U.S. facial skincare product launches boasting anti-aging claims(2) many over-the-counter products are claiming to achieve comparable benefits as prescription anti-aging treatments. The interest in anti-aging products continues to grow, but FDA-approved prescription products with rigorous efficacy and safety standards are still the preferred option when it comes to first-line therapy.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090909/NY69134)

While there is a seemingly endless array of cosmetic products to choose from when it comes to anti-aging products, there is a shortage of products that deliver consistent, optimal results. In these economic times, patients should consult an expert to ensure that they get the best results for their money.

"It is important for consumers to consult an expert before beginning an anti-aging regimen. A dermatologist can provide invaluable insights on what will be most effective for your individual skin type," says Dr. David Bank, Founder and Director of The Center for Dermatology, Cosmetic & Laser Surgery in Mount Kisco, New York. "I always tell my patients to accept no substitutions: FDA approval means a product is safe and effective. And, with proper and consistent use, a prescription product provides real, long-lasting and impressive results."

Although many cosmetic products promise fast results, the results can be short-lived and superficial. Patients who use RENOVA(R) (tretinoin cream) 0.02%, the #1 prescribed, FDA-approved topical treatment clinically proven to reduce fine lines and wrinkles, have seen consistent improvement with ongoing use. In a clinical trial, 85 percent of patients showed continuous improvement over 52 weeks of treatment.

While thousands of cosmetic topical anti-aging skincare products hit shelves every year, none are subjected to the rigorous scientific testing required to gain FDA approval. As a result, none have proven to be more effective than RENOVA(R) in reducing fine facial wrinkles and giving skin a younger, more radiant appearance.

"I've been prescribing RENOVA(R) for 12 years," says Dr. Bank, "RENOVA(R) is a retinoid that contains tretinoin, the gold standard of retinoid therapy for 30 years. I consider RENOVA(R) an essential part of a long-term skincare strategy and recommend it in conjunction with other anti-aging procedures including injectables, lasers and microdermabrasion."

About Ortho Dermatologics:

Ortho Dermatologics is based in Los Angeles, CA and is a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. Experts in medical dermatological and aesthetic products, Ortho Dermatologics offers a complete line of proven anti-aging, anti-acne, anti-fungal, post-procedure care and specialty aesthetic brands that work to restore health and beauty to the skin. Ortho Dermatologics brands include prescription RETIN-A MICRO(R) (tretinoin gel) microsphere, 0.04% and 0.1%, ERTACZO(R) (sertaconazole nitrate) cream, 2%, RENOVA(R) (tretinoin cream) 0.02% and BIAFINE(R) topical emulsion, as well as the company's new medical device, the advanced collagen dermal filler, EVOLENCE(R)dermal filler. For more information, visit www.orthodermatologics.com.

RENOVA(R) 0.02% is indicated as an adjunctive agent for use in the mitigation (palliation) of fine facial wrinkles in patients who use comprehensive skin care and sunlight avoidance programs. RENOVA(R) 0.02% does not eliminate wrinkles, repair sun-damaged skin, reverse photoaging, or restore more youthful or younger skin. The safety and efficacy of using RENOVA(R) 0.02% daily, for greater than 12 months, have not been established. RENOVA(R) 0.02% is proven effective on lightly pigmented skin, Fitzpatrick skin types I, II and III. Do not use RENOVA(R) 0.02% if the patient is taking drugs known to be photosensitizers, pregnant, attempting pregnancy, or nursing. RENOVA(R) 0.02% is a dermal irritant. Almost all patients experience skin reactions, including dryness, peeling, burning/stinging, erythema, and itching. In some patients, this may be severe.

(1) Happi (June 2008) The Latest Word on Anti-Aging Actives: Today's anti-aging skin care formulas are better than ever, agree marketers and dermatologists. Yet, even as more products reach consumers, there are still many questions that must be answered. Retrieved April 16, 2009 from http://www.happi.com/articles/2008/06/the-latest-word-on-anti-aging-actives

(2) Mintel (February 2009). Anti-aging becomes top facial skincare seller in 2008, reports Mintel. Press Release. Retrieved April 16, 2009 from http://www.mintel.com/press-release/Antiaging-becomes-top-facial-skincare-seller-in-2008-reports-Mintel?id=324 09DD0191


'/>"/>
SOURCE Ortho Dermatologics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 07, 2016 , ... Students attending Envision’s summer 2017 ... get hands-on experience in an emergency medical simulation, When Care is Hours Away. ... real-life medical skills that are critical success in a future career and beyond. ...
(Date:12/7/2016)... CITY, UTAH (PRWEB) , ... December 07, 2016 ... ... today announced the release of Smart Device Remote Control through a new partnership ... across all platforms and strengthens its mobile solutions to help businesses maximize their ...
(Date:12/7/2016)... ... December 07, 2016 , ... Castle Dermatology Institute is now ... to restore a more youthful appearance to the face. Dr. Peyman Ghasri and Dr. ... a variety of other treatments, to rejuvenate and renew the facial appearance. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... now promoting to the US market its advanced highly customizable contact technology solutions. ... ODU TURNTAC®. These advanced technologies are ideal for a wide range of applications ...
(Date:12/7/2016)... ... December 07, 2016 , ... AlignLife clinics nationwide are ... children are not fortunate enough to receive bountiful gifts wrapped tightly under a Christmas ... bring to the children of the world. , In exchange for generous donations, customers ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- REPORT OBJECTIVES The report "SPF ... on a market segment, based on geography. Market ... the report. The primary objectives of this report ... through detailed segmentation, 2) market size and forecasts, ... market situation, trends, 3) detailed analysis of current ...
(Date:12/7/2016)... YORK , Dec. 7, 2016 ... report on pulmonary drugs studies the current as ... The stakeholders of this report include companies and ... various pulmonary/respiratory drugs and/or drug-device combinations as well ... This report comprises an elaborate executive summary along ...
(Date:12/7/2016)... DIEGO , Dec. 7, 2016   Arena ... announced that it has completed enrollment in the ralinepag ... receptor agonist targeting the prostacyclin pathway for the treatment ... 60 patients at sites globally. "This marks ... is evidence of our strategic focus on our pipeline," ...
Breaking Medicine Technology: